This inventor holds 1 USPTO granted patent. Top assignee: Corning Incorporated. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Volker H O Eckelt: Innovator in Biomolecular Screening Technology
Introduction
Volker H O Eckelt is a prominent inventor based in Jena, Germany. He has made significant contributions to the field of biomolecular screening, particularly in the development of innovative systems that enhance drug discovery processes. His work is characterized by a focus on label-free high throughput screening methods that are essential for modern pharmaceutical research.
Latest Patents
Eckelt holds a patent for a "Label-free high throughput biomolecular screening system and method." This patent describes a unique and practical solution for enabling label-free high throughput screening (HTS) to aid in the discovery of new drugs. The screening system allows for direct binding assays, enabling the detection of biomolecular interactions between drug candidates and therapeutic targets. It utilizes assay volumes and concentrations that align with current HTS practices in the pharmaceutical industry. The system also incorporates biosensors and surface chemistry to immobilize therapeutic targets, facilitating the detection of biochemical interactions within microplate wells. Additionally, it includes fluid handling and plate handling devices to automate HTS assays.
Career Highlights
Eckelt is associated with Corning Incorporated, a company known for its innovative solutions in materials science and life sciences. His work at Corning has been instrumental in advancing the capabilities of biomolecular screening technologies.
Collaborations
Eckelt has collaborated with notable colleagues such as Stephen Joseph Caracci and Anthony Glenn Frutos, contributing to the development of cutting-edge technologies in the field.
Conclusion
Volker H O Eckelt's contributions to biomolecular screening technology exemplify the innovative spirit of modern inventors. His patent for a label-free high throughput screening system represents a significant advancement in drug discovery methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
